Atlas Trials

Study of HA121-28 in Patients With Non-Small Cell Lung Cancer

Clinical trial NCT05117658 · UNKNOWN

Trial details

NCT number
NCT05117658
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
NSCLC
Start date
2022-02-18
Primary completion
2023-10-01
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.